Showing 521 - 540 of 960 results
ANSTO recently hosted a public Ask Us Anything event on nuclear medicine, sharing information on how we safely manufacture and distribute nuclear medicine across Australia each week to hundreds of hospitals and clinics.
Researchers have discovered a 380-million-year-old heart – the oldest ever found – alongside a separate fossilised stomach, intestine and liver in an ancient jawed fish, shedding new light on the evolution of our own bodies.
The start of ANSTO’s research to support the Securing Antarctica’s Environmental Future (SAEF) program commenced with the official launch of the program and the departure of two students from Queensland University of Technology (QUT), who are affiliated with ANSTO to Antarctica’s Macquarie Island for six months to collect environmental samples as part of the (SAEF) program.
Wombat is a high intensity neutron diffractometer that is primarily used as a high-speed powder diffractometer, but has also expanded into texture characterisation and single-crystal measurement, particularly diffuse scattering.
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
Creating a global energy system that is both environmentally and economically sustainable is unquestionably one of the largest challenges facing the scientific and engineering communities.
ANSTO environmental scientists have alerted the scientific community of the critical need to monitor changes to ice containing potential nuclear fallout that reached Antarctica from 20th century atmospheric weapons testing.
During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).
A groundbreaking international study has provided new insights into global fossil methane emissions, using innovative multi-isotopic atmospheric measurements.
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
By submitting a proposal for Merit Access to ANSTO’s Biosciences, Centre for Accelerator Science, Isotope Tracing, Nuclear Stewardship or the Vivarium capabilities, you are agreeing to the following Terms and Conditions. These Terms and Conditions apply to external merit researchers, scientific collaborators and partners unless there is a specific agreement in place between ANSTO and the home institution of the Principal Investigator.
Supporting healthcare professionals in Australia with easy-to-access resources related to ANSTO’s Gentech® Generator.